Atlas FDA

Saluda Medical Evoke® SCS System

FDA premarket approval P190002/S033 · decided 2024-11-07

Approval details

PMA number
P190002
Supplement
S033
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Saluda Medical Evoke® SCS System
Generic name
Stimulator, spinal-cord, totally implanted for pain relief
Applicant
Saluda Medical Pty, Ltd.
Date received
2024-10-01
Decision date
2024-11-07
Days to decision
37 days
Decision code
OK30
Product code
LGW
Advisory committee
Neurology
Expedited review
No
Location
Atarmon
Statement
to move the final packaging and labeling of the Evoke Charger Kit from Saluda (AU) to Integer/CCC

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.